This inventor holds 1 USPTO granted patent. Top assignee: Dkc Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Doo-Young Chung: Innovator in Benzindocyanine Compounds
Introduction
Doo-Young Chung is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of biomolecular labeling through his innovative work on benzindocyanine compounds. His research focuses on developing novel compounds that enhance the labeling of biomolecules, which is crucial for various scientific applications.
Latest Patents
Doo-Young Chung holds a patent for a benzindocyanine compound for labeling substances, along with the intermediate thereof and a method for preparing the same. This patent represents a breakthrough in the ability to label biomolecules effectively, facilitating advancements in research and diagnostics. The patent is a testament to his expertise and dedication to innovation in the field.
Career Highlights
Chung is currently associated with DKC Corporation, where he continues to push the boundaries of research and development. His work at the company has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Jin Woo Park and Jong Joo Na. Their collaborative efforts contribute to the innovative environment at DKC Corporation, fostering advancements in biomolecular research.
Conclusion
Doo-Young Chung's contributions to the field of biomolecular labeling through his benzindocyanine compound patent highlight his role as an influential inventor. His work not only advances scientific understanding but also paves the way for future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile